Phase III clinical study of MN-10-T AI for patients with osteoporosis at higher fracture risk
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 26 Sep 2017
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Sponsors Asahi Kasei Pharma Corp
- 19 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jan 2017 Status changed from not yet recruiting to recruiting.
- 24 Dec 2016 New trial record